DISCO Pharmaceuticals

Cologne, Germany

DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.

$42.3M raised

Dec 2025

Seed

Manufacturing Pharmaceutical Therapeutics

Top Investors

AbbVie NRW.BANK Sofinnova Partners Panakes Partners M Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about DISCO Pharmaceuticals

How much funding has DISCO Pharmaceuticals raised?

DISCO Pharmaceuticals has raised $42.3M in total funding. The most recent round was Seed. The last funding was announced in December 2025.

Who are DISCO Pharmaceuticals's investors?

DISCO Pharmaceuticals's investors include AbbVie, NRW.BANK, Sofinnova Partners, Panakes Partners, M Ventures.

Where is DISCO Pharmaceuticals headquartered?

DISCO Pharmaceuticals is headquartered in Cologne, Germany.

What does DISCO Pharmaceuticals do?

DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.

What stage is DISCO Pharmaceuticals at?

DISCO Pharmaceuticals is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 11, 2025.

MLA

"DISCO Pharmaceuticals — Funding & Investors." VCBacked, December 11, 2025, https://www.vcbacked.co/company/disco-pharmaceuticals. Accessed July 2, 2026.

APA

VCBacked. (2025). DISCO Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/disco-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=DISCO Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/disco-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 11, 2025.